FDA Action and Securities Investigation Launched into Neogen Corporation Product Recall
1 report, 1 independent
Updated Oct 5
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Levi & Korsinsky notified investors on October 5, 2026, that they had commenced an investigation into Neogen Corporation regarding potential violations of federal securities laws. This follows FDA action concerning the recall of the Neogen Vet product HYCOAT. The product was linked to fungal contamination, which resulted in nearly 100 affected horses and at least 20 horse deaths.
From pr-inside.com
Why it matters
The investigation questions whether Neogen Corporation adequately disclosed the contamination, the resulting horse deaths, and the associated regulatory risks. The company's stock fell approximately 7.2% following the FDA action.
From pr-inside.com
Who's involved
- FDARegulatory body whose action prompted the product recall.
- Center for Devices and Radiological HealthCenter of the U.S. Food and Drug Administration.
Keep exploring
The entities involved
Related events
- The Food and Drug Administration (FDA) oversees product safety and recalls.
- The FDA has listed recalled products, involving the company Colgate.
- The FDA classified the recall of Great Value items, which were distributed in New Mexico, Louisiana, Alabama, and Pennsylvania.
- The FDA has posted a nationwide recall notice.
- Indian products were subject to an FDA recall.